Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Glycomul S
2. Sorbitan Stearate
3. Sorgen 50
4. 1338-41-6
5. Sorbitan Monosterate
6. Schembl285527
7. Sorbitan Monostearate Kosher P
8. Octadecanoic Acid [2-[(2r,3s,4r)-3,4-dihydroxy-2-tetrahydrofuranyl]-2-hydroxyethyl] Ester
Molecular Weight | 430.6 g/mol |
---|---|
Molecular Formula | C24H46O6 |
XLogP3 | 6.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 20 |
Exact Mass | 430.32943918 g/mol |
Monoisotopic Mass | 430.32943918 g/mol |
Topological Polar Surface Area | 96.2 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 417 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
The formulation and characterization of a novel anhydrous organogel formulated as a potential delivery vehicle from a solution of 2 nonionic surfactants, sorbitan monostearate (Span 60) and polysorbate 20 (polyoxyethylene sorbitan monolaurate; Tween 20), in hexadecane at 60DGC, which cools to a white, semi-solid, thermoreversible gel at room temperature, are described. The addition of an aqueous phase (water or niosome suspensions) up to 17% v/v to the oil phase at 60DGC produced water-in-oil and vesicle-in-water-in-oil systems, respectively. The release rate of hydrophilic solute from these gels was found to be lowest when a disperse system of spherical water droplets in the continuous oil phase was formed at high temperatures, compared to the faster release from the gel where the fibril structures acted as nearly continuous aqueous channels running through the organic medium, providing a means of traversing the oil phase.
Murdan S et al; S.T.P. Pharma Sci 6 (1): 44-8 (1996)
1. 1= PRACTICALLY NON-TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) ABOVE 15 G/KG, MORE THAN 1 QT FOR 70 KG PERSON (150 LB).
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-181
WHEN DIGESTED, BOTH THE FATTY ACID AND THE POLYHYDRIC ALCOHOL SORBITAN ARE ABSORBED, BUT THE LATTER IS COMPLETELY EXCRETED IN URINE.
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-181
Market Place
ABOUT THIS PAGE
A Glycomul S manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glycomul S, including repackagers and relabelers. The FDA regulates Glycomul S manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glycomul S API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glycomul S manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glycomul S supplier is an individual or a company that provides Glycomul S active pharmaceutical ingredient (API) or Glycomul S finished formulations upon request. The Glycomul S suppliers may include Glycomul S API manufacturers, exporters, distributors and traders.
click here to find a list of Glycomul S suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glycomul S DMF (Drug Master File) is a document detailing the whole manufacturing process of Glycomul S active pharmaceutical ingredient (API) in detail. Different forms of Glycomul S DMFs exist exist since differing nations have different regulations, such as Glycomul S USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glycomul S DMF submitted to regulatory agencies in the US is known as a USDMF. Glycomul S USDMF includes data on Glycomul S's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glycomul S USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glycomul S suppliers with USDMF on PharmaCompass.
Glycomul S Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glycomul S GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glycomul S GMP manufacturer or Glycomul S GMP API supplier for your needs.
A Glycomul S CoA (Certificate of Analysis) is a formal document that attests to Glycomul S's compliance with Glycomul S specifications and serves as a tool for batch-level quality control.
Glycomul S CoA mostly includes findings from lab analyses of a specific batch. For each Glycomul S CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glycomul S may be tested according to a variety of international standards, such as European Pharmacopoeia (Glycomul S EP), Glycomul S JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glycomul S USP).
LOOKING FOR A SUPPLIER?